Cleaning and sterilization protocol for reused cardiac electrophysiology catheters inactivates hepatitis and coxsackie viruses

Infection Control and Hospital Epidemiology

Volumn 26, Issue 8, 2005, Pages 720-725

  Druce, Julian D ^a   Russell, Jessica S ^a   Birch, Christopher J ^a   Vickery, Karen ^b   Harper, Richard W ^c   Smolich, Joseph J ^c,d  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; ETHYLENE OXIDE; MEDIZYME; NUCLEIC ACID;

ARTICLE; BOVINE DIARRHEA VIRUS; CATHETER; CLEANING; COXSACKIE VIRUS B3; HEART ELECTROPHYSIOLOGY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; INFECTION; INSTRUMENT STERILIZATION;

CATHETERIZATION; DISINFECTANTS; ELECTROPHYSIOLOGY; ENTEROVIRUS B, HUMAN; EQUIPMENT REUSE; HEPATITIS VIRUSES; HUMANS; NUCLEIC ACIDS; STERILIZATION;

EID: 23844482222     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502609     Document Type: Article

References (25)

1. Mickelsen S, Mickelsen C, MacIndoe C, et al. Trends and patterns in electrophysiologic and ablation catheter reuse in the United States. Am J Cardiol 2001;87:351-353.
2. O'Donoghue S, Platia EV. Reuse of pacing catheters: a survey of safety and efficacy. Pacing Clin Electrophysiol 1988;11:1279-1280.
3. Blomstrom-Lundqvist C. The safety of reusing ablation catheters with temperature control and the need for a validation protocol and guidelines for reprocessing. Pacing Clin Electrophysiol 1998;21:2563-2570.
4. Smith JJ, Henderson JA, Baim DS. The Food and Drug Administration and reprocessing of single-use medical devices: a revised policy and new questions. J Vasc Interv Radiol 2002;13:1179-1182.
5. Dunnigan A, Roberts C, McNamara M, Benson DW Jr, Benditt DG. Success of re-use of cardiac electrode catheters. Am J Cardiol 1987;60: 807-810.
6. Avitall B, Khan M, Krum D, Jazayeri M, Hare J. Repeated use of ablation catheters: a prospective study. J Am Coll Cardiol 1993;22:1367-1372.
7. Lindsay BD, Kutalek SP, Cannom DS, Hammill SC, Naccarelli GV. Reprocessing of electrophysiology catheters: clinical studies, regulations, and recommendations. A report of the NASPE Task Force on Reprocessing of Electrophysiological Catheters. Pacing Clin Electrophysiol 2001;24:1297-1305.
8. Aton EA, Murray P, Fraser V, Conaway L, Cain ME. Safety of reusing cardiac electrophysiology catheters. Am J Cardiol 1994;74:1173-1175.
9. Grabsch EA, Grayson ML, Johnson PDR, Yates LA, Harper RW, Smolich JJ. Bactericidal efficacy of sterilizing protocol for re-used cardiac electrophysiology catheters. Am J Cardiol 2002;89:770-772.
10. Druce JD, Russell JS, Birch CJ, Yates LA, Harper RW, Smolich JJ. A decontamination and sterilization protocol employed during reuse of cardiac electrophysiology catheters inactivates human immunodeficiency virus. Infect Control Hosp Epidemiol 2003;24:184-190.
11. Weber DJ, Rutala WA. The emerging nosocomial pathogens Cryptosporidium, Escherichia coli O157:H7, Helicobacter pylori, and hepatitis C: epidemiology, environmental survival, efficacy of disinfection, and control measures. Infect Control Hosp Epidemiol 2001;22:306-315.
12. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003; 362:2089-2094.
13. Pallansch MA, Roos RP. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Fields BN, Knipe DM, Howley PM, et al., eds. Fields Virology, ed. 4. Philadelphia: Lippincott Williams & Wilkins; 2001:723-775.
14. Ganem D. Hepadnaviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al., eds. Fields Virology, ed. 4. Philadelphia: Lippincott Williams & Wilkins; 2001:2923-2969.
15. Lindenbach BD, Rice CM. Flaviviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al., eds. Fields Virology, ed. 4. Philadelphia: Lippincott Williams & Wilkins; 2001:991-1041.
16. Druce JD, Jardine D, Locarnini SA, Birch CJ. Susceptibility of HIV to inactivation by disinfectants and ultraviolet light. J Hosp Infect 1995; 30:167-180.
17. Deva AK, Vickery K, Zou J, West RH, Harris JP, Cossart Y. Establishment of an in-use test method for evaluating disinfection of surgical instruments using the duck hepatitis B model. J Hosp Infect 1996; 33:119-130.
18. Melnick JL, Rennick V, Hampil B, Schmidt NJ, Ho HH. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull World Health Organ 1973;48:263-268.
19. Melnick JL, Wimberly IL. Lyophilized combination pools of enterovirus equine antisera: new LBM pools prepared from reserves of antisera frozen for two decades. Bull World Health Organ 1985;63:543-550.
20. Russell AD. The principles of antimicrobial activity and resistance: disinfection and control. In: Block SS, ed. Disinfection, Sterilization, and Preservation, ed. 5. Philadelphia: Lippincott Williams & Wilkins; 2001:31-55.
21. Adcock WL, MacGregor A, Davies JR, Hattarki M, Anderson DA, Goss NH. Chromatographic removal and heat inactivation of hepatitis B virus during the manufacture of human albumin. Biotechnol Appl Biochem 1998;28:169-178.
22. Borovec S, Broumis C, Adcock W, Fang R, Uren E. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat. Biologicals 1998;26:237-244.
23. Chandra S, Cavanaugh JE, Lin CM, et al. Virus reduction in the preparation of intravenous immune globulin: in vitro experiments. Transfusion 1999;39:249-257.
24. Gauntt CJ, Gomez PT, Duffey PS, et al. Characterization and myocarditic capabilities of Coxsackievirus B3 variants in selected mouse strains. J Virol 1984;52:598-605.
25. Calkins H, Prystowsky E, Carlson M, Klein LS, Saul JP, Gillette P. Temperature monitoring during radiofrequency catheter ablation procedures using closed loop control. Circulation 1994;90:1279-1286.